Sounds like you might be thinking of bimekizumab-bkzx (brand name Bimzelx)! It's a newer biologic that was FDA-approved for adults with moderate to severe HS.
What makes it different from other biologics is that it targets *both* IL-17A and IL-17F, which are key drivers of inflammation in HS. Here's what the clinical Show Full Answer
Sounds like you might be thinking of bimekizumab-bkzx (brand name Bimzelx)! It's a newer biologic that was FDA-approved for adults with moderate to severe HS.
What makes it different from other biologics is that it targets *both* IL-17A and IL-17F, which are key drivers of inflammation in HS. Here's what the clinical trials showed:
- Around 50% of participants saw at least a 50% reduction in HS symptoms after just 4 months
- Some people saw up to a 75% improvement in symptoms
- Benefits lasted through 48 weeks of the study
As with any medication, there are some things to be aware of. Common side effects include:
- Certain infections
- Fatigue
- Injection site reactions
It's always worth having a detailed conversation with your dermatologist to see if this could be a good fit for you, weighing both the potential benefits and risks.
May 26
Join
Your Privacy Choices
